Sentence examples for trials knowledge of from inspiring English sources

"What is needed is know-how of criminal trials, knowledge of international law and overall management skills," he said.

In the absence of randomised controlled trials, knowledge of outcomes associated with medication use during pregnancy is dependent on observational studies.

In the design of clinical trials knowledge of the temporal relationship between HbA1c and diabetic complications is essential so that an appropriate study length is chosen and an improvement in glycemic control can lead to beneficial effects on diabetic complications.

If confirmed in future trials, knowledge of these factors may help to improve discharge management and avoidance of prolonged hospitalizations due to non-medical reasons.

For any intervention trial, knowledge of the natural history of the disease and process of care informs the design and conduct of the trial.

Sample size calculations for clinical studies are usually conducted to determine the total number of patients needed to satisfy a specified power requirement, and their validity is dependent on pre-trial knowledge of nuisance parameters and distributional and modelling assumptions.

The guide queried reasons for joining the trial, knowledge of TB, why isoniazid prophylaxis is important for persons infected with HIV, barriers to trial participation, adequacy of information provided about the trial, perception of the care and treatment provided by trial staff, benefits of being in the trial, and reasons participants stopped taking the study pills.

The implication of medical exclusion on case diagnosis is not known and determining the representativeness of participants selected for trials requires knowledge of disease prevalence in the general population and in individuals with MCI.

These same risk factors can also be used to select at-risk individuals for clinical trials, and knowledge of correlates of circulating 25(OH D also aids in the analysis and interpretation of observational study results.

These findings also highlight that comparing outcomes of thrombolysis (or placebo) treated patients between centres, between countries, or between trials, without knowledge of pre-therapy tissue pathophysiology is likely to be just as potentially inaccurate as making such comparisons without knowledge of baseline clinical factors such as stroke severity and time to treatment.

According to new trials and knowledge of myocardial remodelling as a crucial factor in HF development, slowing or reversing the progression of the disease is recognized as important goal of novel therapy (e.g., inhibition of angiotenzin-renin-aldosteron system) [ 36].